Grünenthal
Generated by Meeveem AI
"Global leader in pain management developing next generation treatments for patients worldwide"
About Grünenthal
Grünenthal is a science-based pharmaceutical company specialising in pain management and related diseases. With over 75 years of research experience and 4,300 employees across 28 countries, the company develops innovative, non-opioid therapies for patients living with acute and chronic pain. Their medicines reach over 100 countries worldwide. As a privately-owned company, Grünenthal combines long-term investment in research with strategic growth. Their integrated operations span discovery, clinical trials, manufacturing, and commercial distribution across Europe, Latin America, and the United States. This commitment to innovation supports their vision of a world free of pain.
4300
Team Members
1946
Founded
Pharma
Sector
Hybrid
Work Environment
Our Vision
A future where effective pain management enables everyone to live without the burden of chronic or acute pain, supported by breakthrough non-opioid therapies and advanced medical technologies that transform patient outcomes globally.
Our Mission
At Grünenthal, our mission is to deliver innovative, science-based pain therapies that address unmet medical needs and improve quality of life for patients worldwide.